However, pretreatment with chidamide but not decitabine significantly inhibited the proliferation of both CD4+ and CD8+ T cells activated by anti-CD3 and anti-CD28 mAbs, suggesting a possible inhibition of anti-leukemia T cell immunity by chidamide in vivo. This evidence concerns the gene CD4 and leukemia.